BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+6.88%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$9.54B
AUM Growth
+$9.54B
(+0.59%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-2.69%
Top 10 Holdings %
Top 10 Hldgs %
82.65%
Holding
144
New
10
Increased
13
Reduced
15
Closed
7
Top Buys
| 1 |
Intellia Therapeutics
NTLA
|
$22.7M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$9.83M |
| 3 |
Merus
MRUS
|
$8.97M |
| 4 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$6.59M |
| 5 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$5.43M |
Top Sells
| 1 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$274M |
| 2 |
Omeros
OMER
|
$11.5M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$9.52M |
| 4 |
ATYR
aTyr Pharma
ATYR
|
$8.42M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$5.46M |
Sector Composition
| 1 | Healthcare | 80.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATYR
126
aTyr Pharma
ATYR
$560M
| – | – |
-2,137,606
| Closed | -$8.42M |
|
|
127
Omeros
OMER
$284M
| – | – |
-749,250
| Closed | -$11.5M |
|
128
Ironwood Pharmaceuticals
IRWD
$201M
| – | – |
-169,163
| Closed | -$1.85M |
|
129
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-1,066,285
| Closed | -$5.42M |
|